Clinical Trials Directory

Trials / Conditions / Stage IV Nasopharyngeal Carcinoma AJCC v8

Stage IV Nasopharyngeal Carcinoma AJCC v8

9 registered clinical trials studyying Stage IV Nasopharyngeal Carcinoma AJCC v8 — 7 currently recruiting.

StatusTrialSponsorPhase
RecruitingTMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Nec
NCT06868433
Emory UniversityPhase 1
RecruitingRemote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin a
NCT06662058
Emory UniversityN/A
RecruitingLovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer,
NCT06636734
Emory UniversityPhase 2
RecruitingTesting the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurre
NCT06029270
National Cancer Institute (NCI)Phase 2
RecruitingA Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
NCT06064097
National Cancer Institute (NCI)Phase 2
RecruitingTesting Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Me
NCT05904080
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTesting the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy
NCT05063552
National Cancer Institute (NCI)Phase 2 / Phase 3
TerminatedTesting the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Ci
NCT04458909
National Cancer Institute (NCI)Phase 3
RecruitingBlood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With
NCT03010150
M.D. Anderson Cancer Center—